Literature DB >> 9034619

Isolated glomeruli and cultured mesangial cells as in vitro models to study immunosuppressive agents.

M Potier1, B L'Azou, J Cambar.   

Abstract

Immunosuppressive agents, such as cyclosporin A (CsA), by their vasoconstrictive properties, induce in vivo in patients and rodents a dramatic fall in renal hemodynamics. The aim of this study is to review the ability of some physiological and/or pharmacological agents which are supposed to be involved in the renal physiopathology of CsA to prevent the contraction induced by CsA in two in vitro glomerular models. Isolated glomeruli are obtained by a sieving method from male Sprague-Dawley rat superficial cortex. Mesangial cells from these isolated glomeruli are cultured in RPM1 1640 medium with 20% FCS in 5% CO2 atmosphere. The area of isolated glomeruli and cultured mesangial cells is assessed by an image analyzer with a video camera. Each glomerulus and cell is its own control and is photographed before incubation with any drug (T0) and then during incubation at 5, 10, 20, and 30 min. Incubations are performed during 30 min with 10(-6) mol/L CsA either with a 10 min pretreatment with the vasoactive agent or without pretreatment. CsA alone induces a time- and dose-dependent decrease in glomerular structure area (-4.7% at 10 min, -10.3% at 20 min, and -12.0% at 30 min for isolated glomeruli); Cremophore excipient or control solute does not induce any significant decrease in surface area. CsA with 10(-6) mol/L verapamil pretreatment induces only a slight decrease: -1.5% at 10 min, -3.0% at 20 min, and -4.8% at 30 min. Calcium blockers nifedipine and felodipine produce similar results. Likewise, with 10(-8) mol/L prostacyclin analog (iloprost), only a slight area decrease in mesangial cells is noted: -1.3% at 5 min, -1.8% at 10 min, and -3.3% at 20 min; with 10(-6) mol/L TXA2 synthesis inhibitor (CGS 12970) the results are -2.0% at 10 min, -3.6% at 20 min, and -4.3% at 30 min. Finally, a similar protective effect can be noted with 10(-5) mol/L theophylline: -0.4; -1.5 and -1.9% at 10, 20, and 30 min. In conclusion, CsA-induced contraction in two in vitro glomerular models can be partially or even totally prevented by pretreatment with various pharmacological agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9034619     DOI: 10.1007/bf00438156

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  35 in total

1.  Dissociation between the immunosuppressive activity of cyclosporine derivatives and their effects on intracellular calcium signaling in mesangial cells.

Authors:  H J Goldberg; P Y Wong; E H Cole; G A Levy; K L Skorecki
Journal:  Transplantation       Date:  1989-04       Impact factor: 4.939

2.  The prostaglandin E1 analog misoprostol reverses acute cyclosporine nephrotoxicity.

Authors:  M S Paller
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

3.  [Qualitative and quantitative study of filtering technics in order to isolate homogeneous glomerular populations].

Authors:  P Martin-Dupont; J Cambar
Journal:  Nephrologie       Date:  1981

4.  Effect of thromboxane synthetase inhibition and angiotensin converting enzyme inhibition on acute cyclosporin A nephrotoxicity.

Authors:  E M Grieve; G M Hawksworth; J G Simpson; P H Whiting
Journal:  Biochem Pharmacol       Date:  1990-11-15       Impact factor: 5.858

5.  Synthesis and action of nitric oxide in rat glomerular mesangial cells.

Authors:  P J Shultz; M A Tayeh; M A Marletta; L Raij
Journal:  Am J Physiol       Date:  1991-10

6.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

Review 7.  The nephrotoxicity of immunosuppressive drugs.

Authors:  W M Bennett
Journal:  Clin Nephrol       Date:  1995-01       Impact factor: 0.975

8.  Site specific regulation in the kidney of endothelin and its receptor subtypes by cyclosporine.

Authors:  S Iwasaki; T Homma; V Kon
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

9.  Characterization of C-type natriuretic peptide receptors in human mesangial cells.

Authors:  J Zhao; N Ardaillou; C Y Lu; S Placier; P Pham; L Badre; J Cambar; R Ardaillou
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

10.  Morphology of cyclosporine nephrotoxicity in the rat.

Authors:  M J Mihatsch; B Ryffel; M Hermle; F P Brunner; G Thiel
Journal:  Clin Nephrol       Date:  1986       Impact factor: 0.975

View more
  3 in total

Review 1.  Tissue-engineered kidney disease models.

Authors:  Teresa M Desrochers; Erica Palma; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2013-12-17       Impact factor: 15.470

Review 2.  High-Throughput Proteomic Approaches to the Elucidation of Potential Biomarkers of Chronic Allograft Injury (CAI).

Authors:  Hilary Cassidy; Jennifer Slyne; Helena Frain; Craig Slattery; Michael P Ryan; Tara McMorrow
Journal:  Proteomes       Date:  2013-09-23

3.  Altered expression profile of renal α(1D)-adrenergic receptor in diabetes and its modulation by PPAR agonists.

Authors:  Xueying Zhao; Yuanyuan Zhang; Michelle Leander; Lingyun Li; Guoshen Wang; Nerimiah Emmett
Journal:  J Diabetes Res       Date:  2014-03-17       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.